(NASDAQ: TYRA) Tyra Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.17%.
Tyra Biosciences's earnings in 2026 is -$131,105,000.On average, 17 Wall Street analysts forecast TYRA's earnings for 2026 to be -$158,601,559, with the lowest TYRA earnings forecast at -$167,266,394, and the highest TYRA earnings forecast at -$144,245,409. On average, 16 Wall Street analysts forecast TYRA's earnings for 2027 to be -$173,058,809, with the lowest TYRA earnings forecast at -$205,149,026, and the highest TYRA earnings forecast at -$141,123,214.
In 2028, TYRA is forecast to generate -$186,832,149 in earnings, with the lowest earnings forecast at -$215,639,602 and the highest earnings forecast at -$84,299,265.